BioT Raises $6.5 Million in Seed Round to Accelerate the Connected Care Revolution

BioT在种子轮融资650万美元加速互联医疗革命

2021-06-29 22:00:07 biospace

本文共1283个字,阅读需4分钟

  BioT's SaaS Platform for Digital Health IoT is Set to Transform Healthcare   [29-June-2021]     TEL AVIV, Israel, June 29, 2021 /PRNewswire/ -- BioT, the market leader in medical devices cloud connectivity and remote care, announces today a $6.5 million Seed Round financing led by Bridges Israel, together with North First Ventures, and XT Hi-Tech. The company unveils that the capital will be used for expanding the team, expediting the next generation of the platform, as well as supporting the growing sales pipeline in the US and in Europe. BioT also shares the new appointment of Daniel Adler as its Chief Executive Officer. Connected Care is quickly becoming a major factor in the healthcare industry by eliminating the need for patients to return to a physician's office for check-ups and monitoring. BioT is poised to disrupt Connected Care by offering innovative medical device providers a secure, HIPAA and GDPR-compliant cloud platform where they can connect their device, execute algorithms, disseminate alerts and engage with patients and caregivers remotely. In our world device providers are spending millions of dollars and years building connected care solutions with questionable cybersecurity measures that do not excel in patient engagement. With dozens of customers utilizing its solutions, BioT offers a proven low-code platform that reduces the skill-set required to develop such systems. When integrating with a solution like BioT, Internet of Medical Things (IoMT) providers can save up to 80% of time and cost to market when compared to creating, building and executing an in-house platform. "BioT invites IoMT innovators to see how a proven reliable platform can expedite their time to market, reduce dramatically their costs and jump over regulatory barriers, while enabling them to continue and focus on their core expertise" says Daniel Adler, Co-Founder & CEO of BioT. "Our mission with BioT is to accelerate the well-needed vision of providing better treatment for patients wherever they are as if they got it at the best hospitals and clinics in the world." "Healthcare must shift from reactive and acute to proactive and preventive. The only way to achieve this shift is through connected healthcare devices and services that allow ongoing remote monitoring and treatment for patients. We, at Bridges Israel, are happy to join forces with the management team at BioT and with N1V and XT Hi-Tech, our co-investors, to support BioT in developing its platform, improving and shortening time to market and enabling the fulfilment of this connected care vision with the goal of improving the health condition of many" says Ran Grodecki, Managing Partner at Bridges Israel. About BioT: BioT is a low-code, easy-to-integrate, cloud-based platform for medical device manufacturers designed to instantly connect patients with caregivers to ensure a seamless continuum of care. BioT offers cutting-edge technology backed by security/regulation liability in a fully customizable, off-the-shelf product that eliminates barriers allowing fast and successful connected care adoption. To learn more about BioT, please visit biot-med.com Contact: Efrat Dahari Head of Marketing efrat@biot-med.com View original content:https://www.prnewswire.com/news-releases/biot-raises-6-5-million-in-seed-round-to-accelerate-the-connected-care-revolution-301321989.html SOURCE BioT  
Biot数字健康物联网SaaS平台将变革医疗保健 [2021年6月29日-6月] 以色列特拉维夫2021年6月29日电/PRNewswire/--医疗设备云连接和远程护理市场领导者BioT今天宣布了一项650万美元的种子轮融资,由Bridges Israel与North First Ventures和XT Hi-Tech共同牵头。该公司宣布,这笔资金将用于扩大团队,加快下一代平台,以及支持在美国和欧洲不断增长的销售渠道。BioT还分享了丹尼尔·阿德勒(Daniel Adler)作为首席执行官的新任命。 联网护理正迅速成为医疗保健行业的一个主要因素,因为它消除了患者返回医生办公室进行检查和监测的需求。 BioT准备通过向创新的医疗设备提供商提供一个安全的、符合HIPAA和GDPR的云平台来扰乱互联护理,在这个平台上,他们可以连接他们的设备,执行算法,传播警报,并与患者和护理人员远程接触。 在我们的世界里,设备提供商正在花费数百万美元和数年时间来构建联网护理解决方案,这些解决方案具有可疑的网络安全措施,在患者参与方面并不出色。BioT提供了一个经过验证的低代码平台,减少了开发此类系统所需的技能集。与BioT这样的解决方案集成时,与创建、构建和执行内部平台相比,医疗物联网(IoMT)提供商可以节省高达80%的上市时间和成本。 Biot联合创始人兼首席执行官丹尼尔·阿德勒(Daniel Adler)表示:“Biot邀请IoMT创新者看看一个被证明可靠的平台如何加快他们的上市时间,大幅降低成本,跨越监管障碍,同时使他们能够继续专注于自己的核心专业知识。”“我们与BioT的使命是加快为患者提供更好治疗的迫切愿景,无论他们在哪里,就像他们在世界上最好的医院和诊所得到的一样。” “医疗保健必须从反应性和急性转向主动性和预防性。实现这一转变的唯一方法是通过联网医疗保健设备和服务,允许对患者进行持续的远程监测和治疗。我们Bridges以色列公司很高兴与BioT的管理团队以及我们的共同投资者N1V和XT Hi-Tech联手,支持BioT开发其平台,改善和缩短上市时间,并实现这一联网护理愿景,以改善许多人的健康状况。”Bridges以色列公司管理合伙人Ran Grodecki说。 关于比奥: BioT是一个低代码、易于集成、基于云的医疗设备制造商平台,旨在立即将患者与护理人员连接起来,以确保无缝连续的护理。BioT提供由安全/监管责任支持的尖端技术,在一个完全可定制的现成产品中消除障碍,允许快速和成功地采用连接护理。要了解更多关于BioT的信息,请访问biot-med.com 联系人: 埃夫拉特·达哈里 市场营销主管 @biot-med.com 查看原始内容:https://www.prnewswire.com/news-releases/biot-raises-6-500-in-seed-round-to-accelerate-the-connected-care-Revolution-301321989.html 源BioT

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文